FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...